High levels of FGFR1 are associated with better overall survival in peripheral nerve sheath sarcomas [173], while activating mutations in the FGFR1 kinase domain have been found in a subset of glioblastoma patients with poor prognosis [174]. Here, FGFR1 is linked to glioblastoma.